Boston Angel Investors →
Founder and CEO, Lighter Capital
Founding Director, Massachusetts Technology Transfer Center
CEO of Zero Locus
Founder and CEO of Brooks Bell Inc.
CEO and co-founder of BoostSuite
Founder and Chairman, Sycamore Networks
Founder, The Haul Company
Founder and Managing Director of DEV
March 28, 2017 ·
April 19, 2017 ·
May 11, 2017 ·
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.